Zenotech [ZENOTECH] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Zenotech Laboratories Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Zenotech Laboratories Ltd. wins in 6 metrics, Innova Captab Ltd. wins in 12 metrics, with 1 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zenotech Laboratories Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 82.73 31.20 Innova Captab Ltd.
Price-to-Book Ratio 2.82 4.05 Zenotech Laboratories Ltd.
Debt-to-Equity Ratio 0.00 32.95 Tie
PEG Ratio 5.79 1.33 Innova Captab Ltd.
EV/EBITDA 18.68 20.49 Zenotech Laboratories Ltd.
Profit Margin (TTM) 8.02% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 20.84% 12.88% Zenotech Laboratories Ltd.
EBITDA Margin (TTM) 20.84% 12.88% Zenotech Laboratories Ltd.
Return on Equity 5.84% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 5.06% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $56.25M $-1.09B Zenotech Laboratories Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return -29.00% -3.19% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 6.62 2.76 Innova Captab Ltd.
Enterprise Value $2.50B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 5.97 2.90 Innova Captab Ltd.
Gross Profit Margin (TTM) 100.00% 35.19% Zenotech Laboratories Ltd.
Revenue per Share (TTM) $7 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $0.55 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.09 -0.33 Innova Captab Ltd.

Zenotech Laboratories Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

ZENOTECH
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zenotech Laboratories Ltd.0.13%-1.28%1.39%-1.00%-8.38%-3.38%
Innova Captab Ltd.-0.63%2.24%2.13%29.82%21.15%16.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zenotech Laboratories Ltd.-29.00%-15.94%2.47%2.12%-12.79%-25.87%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Zenotech Laboratories Ltd. vs Innova Captab Ltd.

MetricZENOTECHINNOVACAP
Market Information
Market Cap i₹2.78B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i7,881578,151
90 Day Avg. Volume i17,746217,693
Last Close₹44.69₹857.00
52 Week Range₹33.55 - ₹67.00₹622.00 - ₹1,020.70
% from 52W High-33.30%-16.04%
All-Time High₹173.59 (Oct 01, 2007)₹1,260.00 (Jan 06, 2025)
% from All-Time High-74.26%-31.98%
Growth Metrics
Quarterly Revenue Growth0.16%0.42%
Quarterly Earnings Growth0.14%0.23%
Financial Health
Profit Margin (TTM) i0.08%0.09%
Operating Margin (TTM) i0.21%0.13%
Return on Equity (TTM) i0.06%0.13%
Debt to Equity (MRQ) i0.0032.95
Cash & Liquidity
Book Value per Share (MRQ)₹16.11₹178.28
Cash per Share (MRQ)₹5.27₹10.22
Operating Cash Flow (TTM) i₹69.82M₹282.88M
Levered Free Cash Flow (TTM) i₹56.13M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Zenotech Laboratories Ltd. vs Innova Captab Ltd.

MetricZENOTECH (Apr 26, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i82.7331.20
Forward P/E iN/A21.90
PEG Ratio i5.791.33
Price to Sales (TTM) i6.622.76
Price to Book (MRQ) i2.824.05
Market Capitalization
Market Capitalization i₹2.78B₹41.43B
Enterprise Value i₹2.50B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i5.972.90
Enterprise to EBITDA i18.6820.49
Risk & Other Metrics
Beta i0.09-0.33
Book Value per Share (MRQ) i₹16.11₹178.28

Financial Statements Comparison: Zenotech Laboratories Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZENOTECH (2025)INNOVACAP (2025)
Revenue/Sales i389.76M12.34B
Cost of Goods Sold i52.64M8.38B
COGS % of Revenue i13.5%67.9%
Gross Profit i337.11M3.96B
Gross Margin i86.5%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i31.79M1.65B
Operating Margin i8.2%13.4%
EBITDA i157.24M2.00B
EBITDA Margin i40.3%16.2%
Pre-Tax Income i106.92M1.71B
Pre-Tax Income % of Revenue i27.4%13.9%
Income Tax i50.79M427.58M
Income Tax % of Revenue i13.0%3.5%
Net Income (Profit) i56.13M1.28B
Profit Margin i14.4%10.4%

Balance Sheet & Liquidity Metrics

MetricZENOTECH (2025)INNOVACAP (2025)
Cash & Equivalents i265.75M155.19M
Total Current Assets i359.89M7.03B
Total Current Assets % of Revenue i92.3%57.0%
Total Current Liabilities i125.87M3.53B
Total Current Liabilities % of Revenue i32.3%28.6%
Long-Term Debt i02.45B
Long-Term Debt % of Revenue i0.0%19.8%
Total Shareholders Equity i961.31M9.59B
Retained Earnings i-1.74B4.53B
Retained Earnings % of Revenue i-447.6%36.7%
Property, Plant & Equipment i22.30M442.93M

Cash Flow Statement Comparison

MetricZENOTECH (2025)INNOVACAP (2025)
Operating Cash Flow i69.82M282.88M
Operating Cash Flow % of Revenue i17.9%2.3%
Capital Expenditures i-38.63M-1.72B
Free Cash Flow i56.25M-1.09B
FCF Margin i14.4%-8.8%
Debt Repayment i0-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricZENOTECHINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i61.03M57.22M
Float Shares i11.70M15.91M
% Held by Insiders i84.53%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i15.47%8.59%

Dividend Analysis & Yield Comparison: Zenotech Laboratories Ltd. vs Innova Captab Ltd.

MetricZENOTECHINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026